Beleggen.nl Markt MonitorMarkt Monitor

Imtech Terug naar discussie overzicht

Donderdag 7 februari , redenen tot kopen

359 Posts
Pagina: «« 1 ... 9 10 11 12 13 ... 18 »» | Laatste | Omlaag ↓
  1. [verwijderd] 7 februari 2013 11:46
    quote:

    Diegy schreef op 7 februari 2013 11:38:

    Toch blijf ik het vreemd vinden, Waarom zou je de presentatie van de cijfers uitstellen als je een relatief kleine tegenvaller hebt van 100 miljoen. Dan is er gewoon meer aan de hand. Als je dat op de dag van de cijfers zou doen dan zou er max 10% van de koers zijn gegaan.

    Je had dit weer gevraagt...

    Mijn antwoord was :
    Justitie stelt ook uit hun uitslag als er nieuw informatie komt en gaat verder onderzoeken toch ? Stabilisatie is slecht voor shorters helaas en de 3 daagse is toch over.

    en [wateenpuinhoop] heeft dit beantwoord op je vraag

    Als blijkt dat er een onjuist feit in de boeken staat ( de vooruitbetaling ) mogen ze niet eens de cijfers presenteren.
    Iets wat onder debiteuren hoort mag niet onder kasgeld staan.
  2. DTJ 7 februari 2013 11:48
    quote:

    suikerbos schreef:

    [quote alias=DTJ id=6721611 date=201302071047]
    [...]

    Dank je
    [/quote]
    Het was inderdaad een prima opsomming, DTJ, ook mijn dank :-)
    Graag gedaan Suikerbos
  3. forum rang 5 Diegy 7 februari 2013 11:52
    Dat was een beste dump. Koer gaat daarna wel weer netjes omhoog moet ik toegeven.
  4. [verwijderd] 7 februari 2013 11:55
    quote:

    Diegy schreef op 7 februari 2013 11:52:

    Dat was een beste dump. Koer gaat daarna wel weer netjes omhoog moet ik toegeven.
    Er is genoeg animo om de koers omhoog te brengen, toch? :-)
  5. DTJ 7 februari 2013 11:59
    Ik blijf Imtech volgen.
    Instappen wacht ik nog even mee.
    Ik ben bang dat ze na deze verschrikkelijke afstraffing ook nog is met een emissie komen.
    Ik hoop dat ik ongelijk heb maar ook vandaag treed er geen overtuigend herstel op.
    Het herstel was in ieder geval van korte duur.
    Het zijn de daytraders die er leuk aan verdienen.
  6. [verwijderd] 7 februari 2013 12:00
    ik lees alleen

    Imtech UK chief insists business is 'unchanged' by £86m Polish hit

    7 February, 2013 | By Luke Cross

    Imtech UK’s chief executive has stressed that his company’s financial position and growth plans are “unchanged” after its Dutch parent group was forced into urgent talks with its banks following an £86 million write down and problems in its Polish business.
  7. [verwijderd] 7 februari 2013 12:01
    ah ! hier zie ik het !

    7 February, 2013 | By Luke Cross

    Imtech UK’s chief executive has stressed that his company’s financial position and growth plans are “unchanged” after its Dutch parent group was forced into urgent talks with its banks following an £86 million write down and problems in its Polish business.

    Imtech UK chief insists business is 'unchanged' by £86m Polish hit

    Paul Kavanagh said the UK company is “one of the stand alone local for local businesses within Imtech”, which operates separately from the Dutch parent group.

    The directors in charge of Imtech’s German division, which runs the Polish operation, stepped down yesterday after parent group Royal Imtech announced it had been “severely harmed” by a lack of payment and likely cancellation of projects at theme park Adventure World Warsaw.

    It cited “possible irregularities” after finding that advanced payments included in the accounts had not been received.

    The Dutch parent group, which saw its share price fall 48 per cent to €10.2 on Monday, said the write downs have left it in breach of its bank covenants.

    Although part of the group, Mr Kavanagh stressed that Imtech UK, which plans to double its revenue to £1bn by 2015, has “a strong position and a record forward order book…with good prospects for further revenue and profit growth”.

    “These fundamentals are unchanged by the events in a separate part of the Imtech NV organisation,” he said.

    “We follow the Imtech model of decentralised control and each individual business within our group has the financial strength, local autonomy and capability to deliver in its local market place,” he added.

    “For many years we have pursued a policy of managed positive growth adhering to this entrepreneurial principle.

    “At the end of 2012 this strategy has left us with a broad based autonomous technical services business with local control, financial strength and strong prospects in a number of markets and regions as well as internationally.”

    Imtech was established in the UK in 2003 and has become one of UK and Ireland’s largest technical services providers through several acquisitions and organic growth. It had a turnover of £515 million in 2011.

    Mr Kavanagh took over as CEO of the M&E and building solutions business from Jim Steele, who remains with the company as group director, and is tasked with the aims of making Imtech “the strongest technical services business in the UK”.

    The £86m it to the parent group relates to three projects for Adventure World Warsaw and one project involving energy-generating bio power stations, also in Warsaw. These projects have a combined value of around £657m

    Parent group Royal Imtech said the departure of the German CEO and CFO was “to safeguard management continuity in Germany in the short term”.

    In a trading update earlier this week, the group said it is delaying publishing its accounts.

    The outgoing German CEO Klaus Betz, has been replaced by Jos Graauwmans, director of human resources at Royal Imtech, who becomes acting CEO of Imtech Deutschland.

    Jan van Middelkoop, CFO Imtech Nederland, will replace Axel Glass and become acting CFO for the German division.

    Permanent successors will be appointed as “quickly as possible,” the group statement said.

    Peter Kronenberg and Peter Eilers, the two other members of the Imtech Deutschland management, will stay on.
  8. [verwijderd] 7 februari 2013 12:05
    quote:

    D The Greek schreef:

    ...'Although part of the group, Mr Kavanagh stressed that Imtech UK, which plans to double its revenue to £1bn by 2015, has “a strong position and a record forward order book…with good prospects for further revenue and profit growth”.

    “These fundamentals are unchanged by the events in a separate part of the Imtech NV organisation,” he said'...
    Klinkt goed
  9. Jos077 7 februari 2013 12:11
    quote:

    Mr. Positief schreef op 7 februari 2013 12:03:

    ik zeg doorschieten naar de € 11,00
    Zou niet eerder het spelletje 10% erbij, 10% eraf gespeeld worden ? Dat gevoel heb ik in ieder geval van de laatste paar dagen..
359 Posts
Pagina: «« 1 ... 9 10 11 12 13 ... 18 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beleggen.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.102
AB InBev 2 5.529
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.951
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.807
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.782
Aedifica 3 925
Aegon 3.258 323.007
AFC Ajax 538 7.088
Affimed NV 2 6.303
ageas 5.844 109.897
Agfa-Gevaert 14 2.062
Ahold 3.538 74.345
Air France - KLM 1.025 35.250
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.048
Alfen 16 25.107
Allfunds Group 4 1.514
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 409
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.638
AMG 971 134.102
AMS 3 73
Amsterdam Commodities 305 6.740
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 15.031
Apollo Alternative Assets 1 17
Apple 5 384
Arcadis 252 8.789
Arcelor Mittal 2.034 320.895
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.342
Aroundtown SA 1 221
Arrowhead Research 5 9.750
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.564
ASML 1.766 109.563
ASR Nederland 21 4.506
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.735
Axsome Therapeutics 1 177
Azelis Group 1 66
Azerion 7 3.439